We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.15%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$474M
AUM Growth
+$427M
Cap. Flow
+$433M
Cap. Flow %
91.18%
Top 10 Hldgs %
10.55%
Holding
454
New
296
Increased
64
Reduced
55
Closed
20

Top Buys

Rank Stock Value
1
OXLC
Oxford Lane Capital
OXLC
+$6.86M
2
BBDC icon
Barings BDC
BBDC
+$6.33M
3
OXSQ icon
Oxford Square Capital
OXSQ
+$5.45M
4
ECC
Eagle Point Credit Company
ECC
+$5.29M
5
FSK icon
FS KKR Capital
FSK
+$5.24M

Top Sells

Rank Stock Value
1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$2.25M
2
ACOR
Acorda Therapeutics
ACOR
+$644K
3
ARRY
Array Biopharma Inc
ARRY
+$605K
4
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
+$603K
5
QURE icon
uniQure
QURE
+$374K

Sector Composition

Rank Sector Weight
1 Financials 23.58%
2 Real Estate 14.99%
3 Energy 13.55%
4 Healthcare 12.23%
5 Materials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDMN
451
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-119,987
Closed -$317K
FPRX
452
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-27,492
Closed -$368K
ONCE
453
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-19,751
Closed -$2.25M
NITE
454
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
– –
-23,777
Closed -$603K
15 16 17 18
19

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, Virtus ETF Advisers held 454 positions worth $474M, up 909% from $47M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Virtus ETF Advisers deployed $433M of net new capital in Q2 2019, opening 296 new positions and adding to 64 existing holdings. Its largest new stake was Oxford Lane Capital: 132,284 shares worth $6.67M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 0.73% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was Array Biopharma Inc, an estimated $605K trimmed.

  • Virtus ETF Advisers's largest Q2 2019 buy was Oxford Lane Capital: 132,284 shares worth $6.67M.
  • Virtus ETF Advisers added most to Dominion Energy in Q2 2019, an estimated $2.63M increase.
  • Virtus ETF Advisers's biggest Q2 2019 reduction was Array Biopharma Inc, cutting an estimated $605K.
  • Virtus ETF Advisers fully exited Spark Therapeutics, Inc. Common Stock in Q2 2019, selling an estimated $2.25M.
  • Virtus ETF Advisers's ten largest holdings make up 11% of its $474M portfolio in Q2 2019.
  • Virtus ETF Advisers opened 296 new positions and closed 20 in Q2 2019.
  • Virtus ETF Advisers's portfolio value rose 909% quarter-over-quarter to $474M.

Based on Virtus ETF Advisers's 13F filing for Q2 2019, filed 13 Aug 2019.